Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New orally active immunosuppressant for combination with ciclosporin

Sep. 9, 1997

Roche seeks European approval for humanized monoclonal antibody

Sep. 5, 1997

Russian scientists report on myelopeptides

Sep. 5, 1997

UDCA suppresses allograft rejection after heart transplant

Sep. 3, 1997

Cortecs granted patent for Flustat

Aug. 29, 1997

Cel-Sci reaches supply agreement with American Red Cross

Aug. 26, 1997

Vertex discloses a novel series of ICE inhibitors

Aug. 25, 1997

TNF-alpha inhibitors reported by Centocor

Aug. 21, 1997

Infanrix Hep B approved in all EU countries

Aug. 19, 1997

Twinrix now available for pediatric use

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...